Expanded monthly production capacity of Betadex Sulfobutyl Ether Sodium.

New extended R & D Center was established in Jinan.

GMP workshop renovation and extension project finished.

Betadex Sulfobutyl Ether Sodium obtained drug clinical trial approval.

Hydroxypropyl Betadex was approved by the U.S FDA, DMF NO.:030168.
Betadex Sulfobutyl Ether Sodium was approved by the U.S FDA, DMF NO.:030167.

Betadex Sulfobutyl Ether Sodium obtained new drug registration application.

Obtained Kosher and HALAL certification.

Hydroxypropyl Betadex obtained approval for the registration of pharmaceutical excipients.

Commenced production of cyclodextrin inclusion compounds-Piroxicam-beta -cyclodextrin Complex, etc.

Obtained the drug production license.

Obtained ISO9001 certification.

Commenced production of Cyclodextrin derivatives - Hydroxypropyl Betadex, Betadex Sulfobutyl Ether Sodium, Methy Beta Cyclodextrin, etc.

Shandong Binzhou Zhiyuan Biotechnology Co.,Ltd was established in Boxing Economic Development Zone, Binzhou, Shandong, China.